key: cord-0991923-al834r9n
authors: Panigrahi, Pradeep K
title: Comment on: Central retinal vein occlusion secondary to varicella zoster retinal vasculitis in an immunocompetent individual during the COVID-19 pandemic - A case report
date: 2022-01-03
journal: Indian J Ophthalmol
DOI: 10.4103/ijo.ijo_2420_21
sha: c75f42aa6dd099aa94f2e86f2b2672f862dd8068
doc_id: 991923
cord_uid: al834r9n

nan

The authors have managed a tricky case in which multiple etiologies had to be ruled out. I have a few observations. The authors have mentioned that there was clinical improvement 3 days following institution of systemic anti-viral therapy. However, in the clinical fundus photograph provided, 3 days following therapy, it seems as if the vascular sheathing along the superotemporal vein has actually increased (worsened) following anti-viral therapy. It would be good to know the duration between initial presentation and institution of systemic therapy. A longer duration between initial presentation and start of therapy might have led to an increase in the vascular sheathing. It will also be interesting to know if there was an increase in visual acuity and decrease in vitreous haze 3 days after starting anti-viral therapy.

Ocular involvement in sarcoidosis is present in 80% of the cases and is frequently manifested before the diagnosis of systemic disease. [2] Posterior segment involvement in sarcoidosis can take the form of retinal vasculitis, perivenous infiltrates with characteristic candle wax drippings, choroiditis patches, and optic nerve granuloma. Absence of characteristic sarcoid lesions does not rule out ocular sarcoidosis. The definitive diagnosis of ocular sarcoidosis is based on biopsy-proven lesions compatible with clinical signs of uveitis. [2] Investigations supportive of ocular sarcoidosis include raised serum angiotensin-converting enzyme (ACE)/lysozyme levels, chest X-ray or high-resolution computed tomography suggestive of bilateral perihilar lymphadenopathy, abnormal liver enzyme tests, and negative tuberculin test in a BCG-vaccinated patient. [2] The present case had raised serum ACE levels. Other laboratory tests supportive of ocular sarcoidosis could have been performed before ruling it out as a possible etiology. In addition, the present case had raised serum homocysteine levels. Elevated serum homocysteine is itself an independent risk factor associated with retinal vein occlusions. [3] Raised serum homocysteine levels can also be associated with systemic thrombosis. The chances of raised homocysteine level as the possible etiology for central retinal vein occlusion in the present case seem highly unlikely. However, as elevated levels of serum homocysteine are associated with thrombotic lesions, treatment should be started to lower its level to prevent any systemic complications in the future.

Financial support and sponsorship Nil.

As described in our report, our case, a young healthy male, who presented with a sudden unilateral decrease in vision, was referred to us with a diagnosis of central retinal venous occlusion (CRVO). Although initially suspected and evaluated for CRVO in the young, including serum homocysteine, the presence of inflammatory features, including the anterior chamber cells and retinal vasculitis, led us to consider toxoplasmosis and sarcoidosis as differentials. The optical coherence tomography features confirming the suspected area of perivascular retinitis along the superior temporal arcade and the increased possibility of Herpes virus retinitis during the COVID-19 pandemic led us to investigate further, revealing polymerase chain reaction (PCR) positivity of aqueous humor for varicella zoster virus (VZV). [3] This also helped us exclude toxoplasmosis, which would have had a different line of treatment.

The treatment with oral valaciclovir was initiated on the fifth day after the onset of symptoms. The steroids were initiated after three days of starting the antiviral therapy. We agree with the author that the retinitis patch around the superior temporal arcade appeared more prominent and larger than at presentation. This was, however, associated with a generalized decrease in vessel caliber and sheathing in other areas. There was also a decrease in retinal edema in the peripapillary region. Thus, we felt there was an overall clinical resolution. The vitreous haze and visual acuity did not worsen after the initiation of antiviral therapy.

In view of the negative Mantoux test and a positive serum angiotensin-converting enzyme, sarcoidosis was considered as a differential. A systemic evaluation by the physician was performed, including a chest X-ray, which was normal. In presence of the highly specific test of PCR for VZV from the aqueous humor being positive, additional tests for sarcoidosis, such as high-resolution computed tomography, were not performed due to financial constraints. The patient is currently under regular follow-up with his physician for both monitoring of sarcoidosis and cardiovascular screening due to elevated serum homocysteine levels. Dietary modifications and vitamin B6, B12, and folic acid supplementation have also been advised. [4] 

COVID-19 vaccine-associated reactivation of uveitis

Central retinal vein occlusion secondary to varicella zoster retinal vasculitis in an immunocompetent individual during the COVID-19 pandemic-A case report

Ocular sarcoidosis: New diagnostic modalities and treatment

Plasma homocysteine in patients with retinal vein occlusion

Cite this article as: Panigrahi PK. Comment on: Central retinal vein occlusion secondary to varicella zoster retinal vasculitis in an immunocompetent individual during the COVID-19 pandemic -A case report

This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. 

Dear Editor, We thank the author for the valuable inputs regarding our case report, [1] and for giving us an opportunity to discuss a few additional aspects, which we were unable to do due to space limitations in the original report. [2]